RAGAN HURT: Open Payments
NPI 1154569820 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$497 in 17 payments from 8 companies in 2025. Trend: 2023 $40 · 2024 $118 · 2025 $497
Food & beverage: $302Education: $195
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $305 |
| GENZYME CORPORATION | 3 | $78 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| Lilly USA, LLC | 1 | $21 |
| Almirall LLC | 1 | $17 |
| Galderma Laboratories, L.P. | 1 | $17 |
| ABBVIE INC. | 1 | $16 |
Products named: ILUMYA, DUPIXENT, LIBTAYO, TALTZ, Seysara, NEMLUVIO, RINVOQ.
Industry payments across TX — which companies pay providers there.
